Medtronic (Switzerland)

Long-term Cost-Effectiveness of an Automated Insulin Delivery System Versus Multiple Daily Injections of Insulin Plus Continuous Glucose Monitoring in Children and Adults With Type 1 Diabetes in Hong Kong

Aim: The MiniMed 780G (MM780G) automated insulin delivery (AID) system has been shown to improve glycemic control in people with type 1 diabetes (T1D). The aim was to determine the long-term cost-effectiveness of the MM780G versus multiple daily injections of insulin plus continu...

The Smart MDI System in People With Type 1 Diabetes and High HBA1C: A Randomized Controlled Trial Demonstrating That Response to Alerts Drives Outcomes

ABSTRACT Aims The aim was to assess the efficacy and safety of the smart multiple daily injections (MDI) system versus MDI plus continuous glucose monitor (CGM) in people with Type 1 diabetes and HbA1c ≥ 8%. Material and Methods After a 3‐week run‐in, 143 participants were random...